GlassScriptPhysician profile
James Brian Davis
NPI 1568102705
$3,442.41
in general payments reported to CMS, 2019-2025
7 companies · $554 in 2025
The $554 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,302 · 2023: $1,086 · 2024: $501 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,140.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,583.17 | 2022-2025 | Augment Injectable, Citrefix, Viaflow |
| Legacy Ortho LLC | $1,200.00 | 2022 | |
| Tulavi Therapeutics, INC. | $179.51 | 2025 | Allay Nerve Cap - Small Nerve Set |
| Angiodynamics, INC. | $125.00 | 2023 | Auryon Laser System 100-120 Vac |
| Heron Therapeutics, INC. | $120.87 | 2023 | Zynrelef |
| Treace Medical Concepts, INC. | $117.66 | 2023 | |
| Acera Surgical, INC. | $116.20 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.